Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent van der Noort

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Seminars in Oncology Nursing|October 9, 2023
A Targeted Discharge Pathway to Reduce Hospital Readmission and Dying in Hospital in Cancer Patients at the End of LifeSannine Buma, Merel van Klinken, Vincent van der Noort
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 25, 2020
Hierarchical clustering of PI3K and MAPK pathway proteins in breast cancer intrinsic subtypesDinja T Kruger, Mark Opdam, Joyce Sanders, et al.
Cancer Chemotherapy and Pharmacology|July 11, 2024
A joint model of longitudinal pharmacokinetic and time-to-event data to study exposure-response relationships: a proof-of-concept study with alectinibLishi Lin, Vincent van der Noort, Neeltje Steeghs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 1, 2018
Trophoblast Glycoprotein is Associated With a Favorable Outcome for Mesothelioma and a Target for Antibody Drug ConjugatesLaurel M Schunselaar, Kim Monkhorst, Vincent van der Noort, et al.
British Journal of Cancer|October 6, 2018
Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequencesDinja T Kruger, Karin J Beelen, Mark Opdam, et al.
Applied Clinical Informatics|October 23, 2025
Implementing a Structured Head and Neck Cancer Care Pathway in an Electronic Health Record: Iterative Process and Effects on Data QualityDominique V C de Jel, J Willemijn van Koevorden, Melanie Singer, et al.
Neuroendocrinology|October 25, 2014
Reliability of proliferation assessment by Ki-67 expression in neuroendocrine neoplasms: eyeballing or image analysis?Marie-Louise F van Velthuysen, Emilie J Groen, Joyce Sanders, et al.
Drug Discovery Today|March 7, 2025
The feasibility of using real world data as external control arms in oncology trialsLishi Lin, Merel J J Lucassen, Vincent van der Noort, et al.
Head & Neck|January 8, 2019
Postlaryngectomy prosthetic voice rehabilitation outcomes in a consecutive cohort of 232 patients over a 13-year periodJapke F Petersen, Liset Lansaat, Adriana J Timmermans, et al.
Pharmacological Research|August 23, 2017
Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancerSiu W Lam, Vincent van der Noort, Tahar van der Straaten, et al.
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Seminars in Oncology Nursing|October 9, 2023
A Targeted Discharge Pathway to Reduce Hospital Readmission and Dying in Hospital in Cancer Patients at the End of LifeSannine Buma, Merel van Klinken, Vincent van der Noort
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 25, 2020
Hierarchical clustering of PI3K and MAPK pathway proteins in breast cancer intrinsic subtypesDinja T Kruger, Mark Opdam, Joyce Sanders, et al.
Cancer Chemotherapy and Pharmacology|July 11, 2024
A joint model of longitudinal pharmacokinetic and time-to-event data to study exposure-response relationships: a proof-of-concept study with alectinibLishi Lin, Vincent van der Noort, Neeltje Steeghs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 1, 2018
Trophoblast Glycoprotein is Associated With a Favorable Outcome for Mesothelioma and a Target for Antibody Drug ConjugatesLaurel M Schunselaar, Kim Monkhorst, Vincent van der Noort, et al.
British Journal of Cancer|October 6, 2018
Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequencesDinja T Kruger, Karin J Beelen, Mark Opdam, et al.
Applied Clinical Informatics|October 23, 2025
Implementing a Structured Head and Neck Cancer Care Pathway in an Electronic Health Record: Iterative Process and Effects on Data QualityDominique V C de Jel, J Willemijn van Koevorden, Melanie Singer, et al.
Neuroendocrinology|October 25, 2014
Reliability of proliferation assessment by Ki-67 expression in neuroendocrine neoplasms: eyeballing or image analysis?Marie-Louise F van Velthuysen, Emilie J Groen, Joyce Sanders, et al.
Drug Discovery Today|March 7, 2025
The feasibility of using real world data as external control arms in oncology trialsLishi Lin, Merel J J Lucassen, Vincent van der Noort, et al.
Head & Neck|January 8, 2019
Postlaryngectomy prosthetic voice rehabilitation outcomes in a consecutive cohort of 232 patients over a 13-year periodJapke F Petersen, Liset Lansaat, Adriana J Timmermans, et al.
Pharmacological Research|August 23, 2017
Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancerSiu W Lam, Vincent van der Noort, Tahar van der Straaten, et al.
Pageof 11